- Home
- TLSI vs IRBT Comparison
TLSI vs IRBT Comparison
Compare TLSI & IRBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- IRBT
- Stock Information
- Founded
- TLSI 2010
- IRBT 1990
- Country
- TLSI United States
- IRBT United States
- Employees
- TLSI N/A
- IRBT N/A
- Industry
- TLSI Medical Specialities
- IRBT Consumer Electronics/Appliances
- Sector
- TLSI Health Care
- IRBT Consumer Discretionary
- Exchange
- TLSI Nasdaq
- IRBT Nasdaq
- Market Cap
- TLSI 150.0M
- IRBT 131.3M
- IPO Year
- TLSI N/A
- IRBT N/A
- Fundamental
- Price
- TLSI $5.05
- IRBT $3.26
- Analyst Decision
- TLSI Strong Buy
- IRBT Hold
- Analyst Count
- TLSI 5
- IRBT 1
- Target Price
- TLSI $10.90
- IRBT N/A
- AVG Volume (30 Days)
- TLSI 112.5K
- IRBT 1.2M
- Earning Date
- TLSI 08-12-2025
- IRBT 11-04-2025
- Dividend Yield
- TLSI N/A
- IRBT N/A
- EPS Growth
- TLSI N/A
- IRBT N/A
- EPS
- TLSI N/A
- IRBT N/A
- Revenue
- TLSI $35,990,000.00
- IRBT $594,601,000.00
- Revenue This Year
- TLSI $56.79
- IRBT N/A
- Revenue Next Year
- TLSI $54.15
- IRBT $69.39
- P/E Ratio
- TLSI N/A
- IRBT N/A
- Revenue Growth
- TLSI 45.50
- IRBT N/A
- 52 Week Low
- TLSI $3.42
- IRBT $1.76
- 52 Week High
- TLSI $5.88
- IRBT $13.06
- Technical
- Relative Strength Index (RSI)
- TLSI 55.11
- IRBT 42.58
- Support Level
- TLSI $4.80
- IRBT $3.04
- Resistance Level
- TLSI $5.24
- IRBT $3.94
- Average True Range (ATR)
- TLSI 0.35
- IRBT 0.21
- MACD
- TLSI 0.02
- IRBT -0.01
- Stochastic Oscillator
- TLSI 72.18
- IRBT 27.22
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About IRBT iRobot Corporation
iRobot Corp is a United state based consumer robot company. It designs and builds robots that assist consumers with the solutions for the activities to be carried out both inside and outside of the home. The company's consumer robot comprises a portfolio of solutions which includes cleaning, mapping and navigation, human-robot interaction, and physical solutions. The company operates in the business segment of Consumer robots. The consumer robot products are provided to the consumers by retail businesses and online stores. The company derives its revenue from the product sales. It sells the products across the United States and around the world.